41
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Condition(s):Hearing Loss; Head and Neck CancerLast Updated:February 3, 2023Not yet recruiting
ATORVASTATIN CALCIUM: 1055 Clinical Trials, Page 5 of 106
Hide Studies Not Open or Pending
42
Bioequivalence Study On Pediatric Appropriate Formulation
Condition(s):HypercholesterolemiaLast Updated:February 18, 2021Completed
43
Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
Condition(s):Nasopharyngeal Carcinoma; Radiation Therapy ComplicationLast Updated:December 4, 2017Suspended
44
Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
Condition(s):CVDLast Updated:September 2, 2015Completed
45
Pharmacokinetic of Everolimus and Atorvastatin Co-administration
Condition(s):Difference of 12-hour AUCLast Updated:February 8, 2013Completed
46
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
Condition(s):Stable Angina; Unstable Angina; Acute Non-ST-segment Elevation Myocardial InfarctionLast Updated:January 8, 2013Unknown status
47
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
Condition(s):Healthy; Pharmacokinetics of AtorvastatinLast Updated:May 27, 2010Completed
48
Atorvastatin in Acute Stroke Treatment
Condition(s):Ischemic StrokeLast Updated:August 26, 2014Completed
49
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Condition(s):Atherosclerosis; Coronary Artery DiseaseLast Updated:August 6, 2020Terminated
50
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
Condition(s):Malignant Disease; Solid Tumor; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Cancer; Relapsed Hematologic MalignancyLast Updated:May 19, 2022Recruiting